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Abstract
Fatty acids (FA) are known to have a number of immunological effects and, accordingly, may play a role in the development of allergic
diseases. We investigated the effect of maternal intake of FA during pregnancy on the risk of allergic rhinitis, wheeze and atopic eczema
in children aged 5 years. The present study analysed data from the Finnish Type 1 Diabetes Prediction and Prevention Nutrition Study,
a population-based birth cohort study with a 5-year follow-up. Complete information on maternal diet (assessed by a validated FFQ)
and International Study of Asthma and Allergies in Childhood-based allergic outcomes was available for 2441 children. Cox proportional
regression and logistic regression were used for the analyses. After adjusting for potential confounding variables, high maternal consump-
tion of butter and butter spreads (hazard ratio (HR) 1·33; 95 % CI 1·03, 1·71) and higher ratio of n-6:n-3 FA (HR 1·37; 95 % CI 1·07, 1·77)
during pregnancy were associated with an increased risk of allergic rhinitis in the offspring by 5 years of age. High maternal intakes of total
PUFA (HR 0·71; 95 % CI 0·52, 0·96) and a-linolenic FA (HR 0·73; 95 % CI 0·54, 0·98) were associated with a decreased risk of allergic rhinitis.
However, these results lost their significance after adjustment for multiple comparisons. Overall, our data suggest that maternal consump-
tion of butter, the ratio of n-6:n-3 FA and intake of PUFA and a-linolenic FA during pregnancy may be potential determinants of allergic
rhinitis in the offspring.
Key words: Allergic rhinitis: Atopic eczema: Children: Fatty acids: Maternal diet: Pregnancy: Wheeze
The increasing prevalence of allergic diseases in Western
countries has partly been linked to changes in the modern
diet(1), particularly changes in the intake of dietary fats(2).
Over the past few decades, consumption of foods rich in
n-6 PUFA has increased, whereas that of n-3 PUFA has
decreased. Arachidonic acid (AA), which is an n-6 PUFA, is
a precursor for pro-inflammatory eicosanoids, while n-3
EPA, is a precursor for anti-inflammatory eicosanoids(3).
Changes in fatty acid consumption may shift the T-helper bal-
ance from type 1 to type 2, which, consequently, may increase
the incidence of IgE-mediated allergic diseases(3,4).
The results of studies on the association between dietary
intake of fats and fatty acids (FA) during pregnancy and
allergic diseases in the offspring are inconsistent. A recent
Japanese cohort study has linked maternal intake of a-linolenic
acid and DHA during pregnancy to a reduced risk of wheezing
in 2-year-old children, while intake of n-6 PUFA and linoleic
acid was associated with an increased risk of eczema(5).
Maternal consumption of butter and margarine was not
associated with atopy in the offspring in an Italian cohort
study(6). Maternal fish consumption decreased the risk of
allergic diseases in the offspring(6–10). In contrast, maternal
*Corresponding author: B. I. Nwaru, fax þ358 401901665, email bright.nwaru@uta.fi
Abbreviations: AA, arachidonic acid; DIPP, Diabetes Prediction and Prevention; FA, fatty acids.
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fish consumption was not associated with asthma or asthma
symptoms in the offspring in a Dutch follow-up study(11).
Further research is required in this area to elucidate the
putative role of dietary fats during pregnancy and early life
in the development of allergies. In the present large cohort
with a relatively long follow-up, we aimed at examining
the effects of maternal intake of dietary fats and a wide
range of FA during pregnancy on the development of allergic
rhinitis, wheeze and atopic eczema in the offspring by the
age of 5 years.
Materials and methods
Subjects
In 1994, the Finnish Type 1 Diabetes Prediction and Preven-
tion (DIPP) study was started. It is a multidisciplinary popu-
lation-based prospective cohort study that examines
potential means to predict and prevent type 1 diabetes(12).
Newborn infants with human leucocyte antigen (HLA)-
conferred susceptibility to type 1 diabetes are recruited from
three university hospitals in Finland (Turku, Oulu and
Tampere) and monitored at 3–12-month intervals for dia-
betes-associated antibodies, growth and environmental
exposures. The present study was conducted according to the
guidelines laid down in the Declaration of Helsinki and all pro-
cedures involving human subjects were approved by the ethics
committees of the Universities of Oulu and Tampere. Written
informed consent was obtained from the parents.
In September 1996 and October 1997, the DIPP Nutrition
Study was started within the framework of the DIPP study in
Oulu (Northern Finland) and Tampere (Southern Finland),
respectively(13), examining the relationship of maternal diet
during pregnancy and lactation, and the child’s diet
during infancy to the development of type 1 diabetes,
allergic diseases and asthma in childhood. At the age of
5 years, 3523 children who were still participating in the
dietary follow-up (born between 20 October 1997 and
29 February 2004) were invited to take part in the allergy
study by completing a questionnaire on the child’s history
of allergic symptoms. Altogether 3253 (92 % of those invited)
participated in the allergy study. Of these, complete infor-
mation on maternal diet during pregnancy was available
for 2441 children (75 % of those who participated in the
allergy study).
Dietary assessment
Maternal food consumption during the last month before the
beginning of maternity leave, i.e. the 8th month of preg-
nancy, was assessed using a validated 181-item FFQ(14).
The FFQ specially reflected the diet of Finnish women of
childbearing age. Mothers received the FFQ after delivery
and recorded the foods they had eaten during the month
preceding their pregnancy leave. The use of supplements
during the whole pregnancy period was also recorded.
The FFQ was returned to the study centre at the child’s
3-month visit and was checked by a study nurse. Software
of the National Institute for Health and Welfare, Helsinki,
Finland, was used to convert the food consumption data to
daily nutrient intake, taking into account women’s individual
choices of fats used in food preparations and baking, and oils
used for salad dressing(15). The dietary exposures investigated
in the present study include the main dietary fats (butter,
margarine and oils) and a range of FA (SFA, MUFA, PUFA
and their subsidiaries). In the validation of the FFQ against
a 10 d food records, the energy-adjusted and attenuation-
corrected correlation coefficients for these dietary exposures
were as follows: total fat (0·48), butter (0·77), margarines
(0·64) and oils (0·22), SFA (0·55), MUFA (0·34), PUFA (0·47),
n-3 PUFA (0·39) and n-6 PUFA (0·49). Overall, 70 % of
the foods and 69 % of the nutrients fell into the same or
adjacent quintiles(14).
Assessment of allergic outcomes
At the age of 5 years, families of the participating children
completed a questionnaire modified from the International
Study of Asthma and Allergies in Childhood questionnaire
on the child’s history of allergic symptoms(16,17). Allergic rhini-
tis was defined as sneezing, nasal congestion or rhinitis other
than with respiratory infections, accompanied by itching of
the eye and tearing during the previous 12 months. Wheezing
was defined as parental ‘yes’ answer on whether the child has
had any of the following during the past 12 months: wheezy
sound in respiration; wheezy sound in respiration in connec-
tion with physical activity; difficulties in respiration in the
morning on waking up; wheezy respiration without having
the sniffles or respiratory infection; dry cough at nights not
associated with common colds or respiratory infections.
Age of the onset of rhinitis and wheeze was indicated by
the date of the doctor-made diagnosis. Atopic eczema was
defined with a positive answer to the question: ‘Has your
child ever had atopic eczema?’
Sociodemographic and perinatal characteristics
Information on the child’s sex, maternal age, maternal
educational level and the number of siblings was recorded
in a structured questionnaire completed by the parents after
the delivery. Information on duration of gestation, birth
weight and height, and maternal smoking during pregnancy
was received from the Medical Birth Registries of Oulu and
Tampere University Hospitals.
Statistical analysis
The distribution of maternal intake of n-3 and n-6 PUFA in the
study population was analysed using the t test and ANOVA.
Cox proportional hazards regression was used to estimate
the risk of the onset of allergic rhinitis and wheeze (because
we had the follow-up times for these outcomes), while
logistic regression was used to estimate the prevalence of
atopic eczema. The FA were energy adjusted by the
residual method(18) while total energy intake was included
in the models containing the dietary fats. The dietary
Fatty acids and allergies in the offspring 721
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variables were categorised in quarters, and the two middle
quarters were combined and used as the reference category.
A priori, we judge that the two middle quarters constitute
those with average diet intake in the study population, thus
using them as the reference category and comparing the
other two extreme quarters seems logical. Selection of con-
founding covariates was based on their relationships with
the exposure and/or the outcome and, in respect of nutrients,
on earlier findings. In the adjusted models, the following cov-
ariates were included and categorised as shown in Table 1: sex
of child, hospital of birth, duration of gestation, maternal age
at delivery, maternal basic education, maternal smoking
during pregnancy, mode of delivery, number of siblings at
the time of the child’s birth, parental asthma, parental allergic
rhinitis, pets at home by 1 year of age. A second adjusted
model was computed for the FA in which potentially con-
founding nutrients, vitamin C, Zn, Se, vitamin D and vitamin
E were included as additional covariates. Correction for mul-
tiple comparisons was performed using the Bonferroni adjust-
ments. All analyses were computed using SPSS version 15.0
(SPSS, Inc., IL, USA).
Results
Participants in the allergy study were generally not syste-
matically different from non-participants regarding the
Table 1. Distribution of maternal intake of n-3 and n-6 PUFA by the characteristics of the participating children
(Mean values with their standard errors, n 2441)
Maternal intake of n-3 PUFA Maternal intake of n-6 PUFA
Characteristics Mean (g/d) SD P * Mean (g/d) SD P *
Sex 0·752 0·186
Boys 3·2 1·2 10·7 3·7
Girls 3·2 1·3 10·9 4·3
Delivery hospital 0·129 0·013
Oulu (Northern Finland) 3·1 1·3 10·5 3·8
Tampere (Southern Finland) 3·2 1·7 10·9 4·2
Duration of gestation 0·634 0·139
Quarter: #38·90 weeks 3·1 1·2 10·5 3·7
Quarter: 39·00–39·90 weeks 3·2 1·2 10·8 3·8
Quarter: 40·00–40·70 weeks 3·2 1·2 10·9 4·0
Quarter: .40·70 weeks 3·2 1·3 11·0 4·5
Missing
Maternal age ,0·001 0·355
,25 years 3·0 1·2 10·6 4·1
25–29 years 3·1 1·2 10·7 4·2
30–34 years 3·2 1·3 10·8 3·9
$35 years 3·3 1·3 11·0 3·8
Maternal basic education ,0·001 0·016
Less than high school 3·0 1·3 10·5 4·2
High school graduate 3·2 1·3 10·9 3·9
Maternal smoking during pregnancy 0·947 0·015
No 3·2 1·3 10·7 3·8
Yes 3·1 1·2 12·5 7·1
No information 3·2 1·4 11·3 5·2
Mode of delivery 0·923 0·888
Vaginal delivery 3·2 1·2 10·8 4·0
Forceps or suction 3·2 1·2 10·8 3·5
Caesarean section 3·1 1·4 10·9 4·5
Number of siblings 0·006 0·020
None 3·1 1·2 10·5 3·8
One 3·3 1·3 11·1 4·1
Two or more 3·2 1·3 10·9 4·4
Parental asthma 0·039 0·136
No 3·2 1·3 10·8 4·0
Yes 3·1 1·3 10·6 4·1
No information 2·7 1·0 9·5 3·5
Parental allergic rhinitis 0·194 0·386
No 3·2 1·3 10·8 4·1
Yes 3·1 1·3 10·8 3·9
No information 3·4 1·3 11·3 4·8
Atopic eczema by 6 months of age 0·318 0·656
No 3·2 1·3 10·8 4·1
Yes 3·2 1·2 10·7 3·9
Pets at home during the first year 0·587 0·090
No 3·2 1·3 10·7 3·9
Yes 3·2 1·3 11·0 4·3
* Based on the t test or ANOVA.
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background characteristics of the study population either in
absolute or relative terms, except for the place of birth:
those from Southern Finland were slightly more likely not to
take part in the study (10 %) than those from Northern Finland
(4 %; P,0·001). The mean total daily intake of energy for
participating mothers was 11 386 (SD 3148) kJ. Protein
accounted for 16 % (mean intake 110 g; SD 31), fat for 35 %
(105 g; SD 34) and total carbohydrates for 49 % (325 g; SD 95)
of the total energy intake. The mean total daily intake of SFA
was 45 (SD 17) g, MUFA 37 (SD 12) g, n-3 PUFA 3·2 (SD 1·3) g
and n-6 PUFA 10·8 (SD 4·0) g. None of the women was
taking fatty acid supplements during pregnancy.
Significantly higher mean daily intake of n-3 PUFA was seen
among women over 35 years of age, women with high school
degree, children with one sibling and children without
parental asthma (Table 1). A higher intake of n-6 PUFA was
seen among those from Southern Finland, women with high
school degree, women who smoked during pregnancy and
among children with one sibling. Duration of gestation for
more than 40 weeks and having a pet at home during
the first year of the child were associated with a decreased
risk of atopic eczema, whereas children with parental
asthma and rhinitis were at increased risk of atopic eczema.
A decreased risk of allergic rhinitis was seen among girls,
while children with parental asthma, those with parental
rhinitis and those who had atopic eczema by 6 months of
age appeared to have an increased risk of rhinitis. Increasing
maternal age was associated with decreased risk, whereas
increasing number of siblings increased the risk of wheeze
(Table 2).
After adjusting for potential confounders, none of the
dietary fats or FA was significantly associated with atopic
eczema and wheeze. For allergic rhinitis, high maternal
consumption of butter and butter spreads was associated
with an increased risk of the emergence of allergic rhinitis
in the offspring by the age of 5 years (Table 3). A higher
ratio of n-6:n-3 FA during pregnancy was associated with
an increased risk of allergic rhinitis (Table 4). On the other
hand, a decreased risk of allergic rhinitis was observed
with high intakes of total PUFA and a-linolenic FA (Table 4).
These results did not change in the models adjusted addition-
ally for the effect of vitamin C, Zn, Se, vitamin D and
vitamin E (Table 5). However, after a Bonferroni correction
for multiple comparisons, these results lost their statistical
significance.
Discussion
The results from the present study show that high maternal
consumption of butter and higher ratio of n-6:n-3 FA during
pregnancy were associated with an increased risk of allergic
rhinitis in the offspring by the age of 5 years. Conversely,
high maternal intake of total PUFA and a-linolenic FA was
associated with a decreased risk of rhinitis in the offspring.
Adjustment for the effects of vitamin C, Zn, Se, vitamin D
and vitamin E did not alter these results, but the results
were no longer significant after correction for multiple
comparisons.
As a prospective study, the determination of dietary intake
before the emergence of the outcomes ensured minimising
bias related to the selection of the subjects. The FFQ used in
the present study was validated and is suitable for the assess-
ment of dietary intake among childbearing Finnish women(14).
The rationale for the dietary assessment was to get a general
picture of the diet of the mothers during the first 8 months
of pregnancy. We assumed that by assessing the maternal
diet during the month preceding the maternity leave (i.e. the
8th month of pregnancy), we obtained a more appropriate
overall picture of the maternal diet during pregnancy than
by assessing it over the period of the last month before deliv-
ery (the 9th month) when most of the mothers did not work
outside the home any longer. Dietary measurement error is
most consequential if a proportion of subjects are misclassified
according to the exposure. There are three recommended val-
idity estimates for nutrients of interest in epidemiological
studies: Spearman’s correlation coefficients should be above
0·5; more than 50 % of subjects should be correctly classified;
less than 10 % of subjects should be grossly misclassified into
thirds(19). In terms of dietary fats, the greatest misclassifications
were found for MUFA (9 % of the subjects grossly misclassi-
fied). Although biomarker assessments represent a precise
estimate of the FA, they are limited by being unable to
assess the long-term nutrient status. In this case, the FFQ is
beneficial, since long-term and habitual intake can be
measured. By assessing maternal dietary intake during the
8th month of pregnancy, we aimed at estimating the overall
picture of maternal diet during the first 8 months of preg-
nancy. Although some seasonal variations have been observed
in maternal diet during pregnancy as a result of fluctuations in
nutrient intakes(20), it has been suggested that such changes
may be difficult to accurately detect with the rather imprecise
dietary assessment methods currently available(21). Conse-
quently, our generalisation of maternal dietary intake during
the 8th month to the whole pregnancy period may remain
only a rough approximation. In order to improve the classifi-
cation of dietary fats, the grouping and brand names of
spreads in our FFQ are continuously checked and updated.
Most importantly, the overall quintile notation was acceptable
for all FA.
There is considerable heterogeneity in respiratory symp-
toms among children. Consequently, we found associations
between FA and rhinitis but not with eczema and wheeze.
We lack the knowledge on the mechanisms and the optimal
timing of exposure to lower or higher FA levels to influence
the development of the different allergic diseases. To exclude
younger children having transient respiratory symptoms
related to viral infections, the endpoints in the present study
were measured in subjects aged 5 years. Because of the lack
of data, the child’s fat and/or fatty acid intake was not
included into our models as a possible confounding factor;
thus, we cannot totally rule out that the present results
might not have been influenced by dietary intake during
infancy. Previous findings have suggested that processes
leading to allergic diseases can be initiated very early in
the immune development(22,23). The complex relationship
between early nutrition and allergic outcomes emphasises
Fatty acids and allergies in the offspring 723
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Table 2. Relationship of characteristics of the participating children (n 2441) to the incidence of atopic eczema, allergic rhinitis and wheeze by 5 years of age
(Number of participants, percentages, odds ratios, hazard ratios and 95 % confidence intervals)
Frequency
(all)
Atopic
eczema
endpoints Atopic eczema
Allergic
rhinitis
endpoints Allergic rhinitis
Wheeze
endpoints Wheeze
Characteristics n % n % OR 95 % CI n % Hazard ratio 95 % CI n % Hazard ratio 95 % CI
Sex P¼0·857 P¼0·004 P¼0·841
Boys 1272 52 480 38 1 212 17 1 358 29 1
Girls 1169 48 446 38 1·02 0·86, 1·20 147 13 0·73 0·59, 0·91 292 25 0·98 0·80, 1·20
Delivery hospital P¼0·450 P¼0·207 P¼0·337
Oulu (Northern Finland) 855 35 341 40 1 119 14 1 212 25 1
Tampere (Southern Finland) 1586 65 585 37 0·88 0·74, 1·05 240 15 1·16 0·92, 1·45 438 28 1·11 0·90, 1·36
Duration of gestation P¼0·004 P¼0·713 P¼0·591
Quarter: #38·90 weeks 597 25 235 39 1 79 13 1 171 29 1
Quarter: 39·00–39·90 weeks 565 23 205 36 0·86 0·68, 1·09 85 15 1·12 0·82, 1·51 153 28 0·85 0·65, 1·11
Quarter: 40·00–40·70 weeks 614 25 265 43 1·16 0·92, 1·46 99 16 1·18 0·88, 1·59 152 25 0·85 0·64, 1·13
Quarter: .40·70 weeks 646 27 216 33 0·78 0·61, 0·98 95 15 1·06 0·79, 1·44 179 27 0·92 0·70, 1·21
Missing 19 1 5 26 1 5 4 21
Maternal age P¼0·091 P¼0·561 P¼,0·001
, 25 years 361 15 131 36 1 57 16 1 117 33 1
25–29 years 871 36 352 40 1·20 0·93, 1·55 127 15 0·94 0·68, 1·31 227 26 0·65 0·49, 0·88
30–34 years 751 31 289 38 1·10 0·84, 1·42 114 15 1·12 0·79, 1·59 179 24 0·68 0·50, 0·93
$ 35 years 458 19 154 33 0·89 0·67, 1·19 61 13 0·95 0·64, 1·41 127 28 0·44 0·30, 0·63
Maternal basic education P¼0·926 P¼0·124 P¼0·415
Less than high school 834 34 315 38 1 132 16 1 219 27 1
High school graduate 1558 64 594 38 1·01 0·85, 1·20 220 14 0·84 0·67, 1·05 414 27 1·09 0·88, 1·35
Missing 49 2 17 35 7 12 17 35
Maternal smoking during pregnancy P¼0·452 P¼0·640 P¼0·761
No 2177 89 830 38 1 325 15 1 581 27 1
Yes 29 1 8 28 0·61 0·27, 1·38 6 21 1·46 0·64, 3·31 8 28 1·39 0·50, 3·89
No information 194 8 77 40 1·06 0·78, 1·43 24 12 0·95 0·63, 1·44 49 26 1·08 0·74, 1·58
Missing 41 2 11 27 4 10 12 29
Mode of delivery P¼0·336 P¼0·245 P¼0·234
Vaginal delivery 1959 80 758 39 1 279 14 1 508 26 1
Forceps or suction 158 6 57 36 0·89 0·63, 1·25 33 21 1·38 0·94, 2·01 46 30 1·13 0·76, 1·68
Caesarean section 309 13 107 35 0·84 0·65, 1·08 47 15 1·00 0·73, 1·39 94 31 1·27 0·96, 1·68
Missing 15 1 4 27 0 0 2 13
Number of siblings P¼0·427 P¼0·863 P¼0·001
None 1122 46 427 38 1 177 16 1 314 28 1
One 750 31 296 39 1·08 0·89, 1·30 101 14 0·93 0·72, 1·21 181 24 1·28 1·01, 1·63
Two or more 546 22 197 36 0·93 0·75, 1·15 79 16 0·95 0·70, 1·28 150 28 1·68 1·27, 2·24
Missing 23 1 6 26 2 9 5 22
Parental asthma P,0·001 P¼0·038 P¼0·998
No 2004 82 716 36 1 269 13 1 486 25 1
Yes 381 16 185 49 1·70 1·36, 2·12 81 21 1·39 1·08, 1·79 149 40 1·00 0·80, 1·25
No information 33 1 15 45 1·56 0·78, 3·15 5 15 1·28 0·56, 1·28 8 24 1·04 0·29, 3·69
Missing 23 1 10 43 4 17 7 32
Parental allergic rhinitis P,0·001 P,0·001 P¼0·178
No 797 33 227 28 1 61 8 1 150 19 1
Yes 1512 62 650 43 1·92 1·59, 2·31 280 19 2·32 1·74, 3·08 462 31 0·90 0·71, 1·13
No information 109 4 43 39 1·68 1·11, 2·54 16 15 1·65 0·92, 2·99 35 33 1·44 0·82, 2·55
Missing 23 1 6 26 2 9 3 14
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the need for consistent and thorough assessment of maternal
diets throughout the duration of pregnancy and the child’s
diet throughout early years. However, duration of exclusive
and total breast-feeding has not been related to allergic out-
comes in our cohort.
After adjusting for multiple comparisons, the results no
longer achieved statistical significance. Therefore, we suggest
caution in the interpretation of the present findings. However,
we note that the hypotheses linking each of the FA and
allergies are mixed, and the precise mechanisms of the role
of fatty acids on the occurrence of allergies are not clearly
elucidated. Consequently, we believe that each of the associ-
ations between the studied FA and the allergic outcomes
should be judged on its own merit. Furthermore, the limited
and conflicting reports in this area of research signify that
reproducibility of these results in further studies would be
crucial to rule out any chance finding.
The genetic susceptibility to type 1 diabetes of our study
subjects may constrain the generalisability of the present
results. Type 1 diabetes is associated with T helper cell 1
(Th1) immune responses, while allergic diseases are related
to T helper cell 2 (Th2)-type responses(24). In addition to the
complexities surrounding the components of the immune
system that relate to the generation of Th1 and Th2 responses,
it is inconclusive how type 1 diabetes and allergies may be
associated(25). However, the cumulative incidence of allergies
in the present study paralleled that observed in the general
Finnish population(17,26). Furthermore, our subjects were
unselected in terms of history of allergy, thus minimising
bias towards more selection of children with a positive history
for allergic diseases. Participants in the present allergy
study were generally not systematically different from non-
participating women regarding the background characteristics,
suggesting that differential loss to follow-up was minimised
in the present study.
The immunological properties of FA have been elabo-
rated(3,27), particularly that of the n-3 and n-6 families,
which represent the most widely studied FA. While n-6
PUFA may possess pro-inflammatory properties, n-3 PUFA
are thought to act as anti-inflammatory mediators(27,28).
These effects may be prominent during fetal and early life,
emphasising the consequences of maternal intake of FA
during pregnancy(29,30). In the present study, while both n-6
and n-3 PUFA were not appreciably related to the outcomes,
total PUFA and a-linolenic FA, however, were associated
with a decreased risk of rhinitis. In addition to our present
findings, our earlier report has shown an unclear association
between maternal intake of PUFA during pregnancy and aller-
gen-specific IgE sensitisation in the offspring in a different
subject series of this cohort(31). In a Japanese study, maternal
intake of a-linolenic acid during pregnancy was associated
with a reduced risk of wheezing in 2-year-old children(5).
Also, consistent with the present findings, no association
was seen between any of the FA and suspected eczema
in the Japanese children at the age of 3–4 months(32).
The younger age of children in the Japanese cohort
makes it likely that their wheezing symptoms may be a
result of viral infections, which are usually unrelated toT
a
b
le
2
.
C
o
n
ti
n
u
e
d
F
re
q
u
e
n
c
y
(a
ll)
A
to
p
ic
e
c
z
e
m
a
e
n
d
p
o
in
ts
A
to
p
ic
e
c
z
e
m
a
A
lle
rg
ic
rh
in
it
is
e
n
d
p
o
in
ts
A
lle
rg
ic
rh
in
it
is
W
h
e
e
z
e
e
n
d
p
o
in
ts
W
h
e
e
z
e
C
h
a
ra
c
te
ri
s
ti
c
s
n
%
n
%
O
R
9
5
%
C
I
n
%
H
a
z
a
rd
ra
ti
o
9
5
%
C
I
n
%
H
a
z
a
rd
ra
ti
o
9
5
%
C
I
A
to
p
ic
e
c
z
e
m
a
b
y
6
m
o
n
th
s
o
f
a
g
e
P
,
0
·0
0
1
P
¼0
·2
8
7
N
o
2
0
0
7
8
2
5
1
4
2
6
–
2
3
9
1
2
1
4
8
9
2
5
1
Y
e
s
3
8
4
1
6
3
8
4
1
0
0
–
1
1
8
3
1
2
·7
1
2
·1
7
,
3
·3
9
1
4
7
3
9
1
·1
3
0
·9
0
,
1
·4
1
M
is
s
in
g
5
0
2
2
8
5
6
–
2
4
1
4
3
0
P
e
ts
a
t
h
o
m
e
d
u
ri
n
g
th
e
fi
rs
t
y
e
a
r
P
¼0
·0
1
8
P
¼0
·8
0
8
P
¼0
·1
8
2
N
o
1
6
4
7
6
7
6
5
3
4
0
1
2
5
2
1
5
1
4
5
8
2
8
1
Y
e
s
7
8
3
3
2
2
7
2
3
5
0
·8
1
0
·6
8
,
0
·9
6
1
0
7
1
4
0
·9
7
0
·7
7
,
1
·2
3
1
9
2
2
5
1
·1
5
0
·9
4
,
1
·4
3
M
is
s
in
g
1
1
1
1
9
0
0
0
0
T
o
ta
l
2
4
4
1
1
0
0
9
2
6
1
0
0
3
5
9
1
0
0
6
5
0
1
0
0
Fatty acids and allergies in the offspring 725
B
ri
ti
sh
Jo
u
rn
al
o
f
N
u
tr
it
io
n
Table 3. Association between maternal consumption of dietary fats during pregnancy and prevalence of atopic eczema and incidence of allergic rhinitis and wheeze in 5-year-old children
(Hazard ratios (HR), odds ratios and 95% confidence intervals)
Atopi eczema Allergic rhinitis Wheeze
Unadjusted† Adjusted‡ Unadjusted† Adjusted‡ Unadjusted† Adjusted‡
Food variables HR 95 % CI HR 95 % CI OR 95 % CI OR 95 % CI HR 95 % CI HR 95 % CI
Butter and butter spreads
First quarter (,4·72 g/d) 0·91 0·74, 1·11 0·94 0·76, 1·17 1·10 0·85, 1·43 1·07 0·81, 1·42 1·07 0·84, 1·35 1·09 0·84, 1·41
Second and third quarters (4·7–19·82 g/d) 1 1 1 1 1 1
Fourth quarter (19·83–128·38 g/d) 1·09 0·89, 1·34 1·05 0·85, 1·30 1·42* 1·11, 1·81 1·33* 1·03, 1·71 0·84 0·67, 1·06 0·80 0·62, 1·03
Industrial fats§
First quarter (,4·84 g/d) 0·96 0·78, 1·17 0·94 0·76, 1·17 0·81 0·62, 1·05 0·76 0·58, 1·00 1·02 0·81, 1·29 0·95 0·74, 1·23
Second and third quarters (4·85–10·85 g/d) 1 1 1 1 1 1
Fourth quarter (10·86–115·93 g/d) 0·94 0·75, 1·17 0·95 0·76, 1·20 0·91 0·69, 1·20 0·89 0·67, 1·18 1·21 0·94, 1·56 1·16 0·89, 1·52
Margarines
Non-consumers 1 1 1 1 1 1
Consumers (0·06–120 g/d) 0·92 0·78, 1·09 0·92 0·77, 1·09 0·88 0·72, 1·09 0·89 0·72, 1·11 1·03 0·85, 1·26 1·04 0·84, 1·29
Oils
First quarter (,7·25 g/d) 0·98 0·80, 1·20 0·91 0·73, 1·13 0·92 0·71, 1·19 0·86 0·66, 1·12 0·87 0·68, 1·10 0·88 0·68, 1·14
Second and third quarters (7·25–16·37 g/d) 1 1 1 1 1 1
Fourth quarter (16·38–145·00 g/d) 0·97 0·80, 1·19 1·01 0·81, 1·26 0·79 0·61, 1·03 0·81 0·61, 1·07 0·98 0·78, 1·24 1·05 0·82, 1·35
*P,0·05.
† Total energy included in the model.
‡ Adjusted for total energy, sex of child, hospital of birth, duration of gestation, maternal age at delivery, maternal basic education, maternal smoking during pregnancy, mode of delivery, number of siblings at the time of the child’s
birth, parental asthma, parental allergic rhinitis, pets at home by 1 year of age.
§ Industrial fats: industrial fat mixes and animal fats (grease, suet, lard).
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Table 4. Association between maternal fatty acid intake during pregnancy and prevalence of atopic eczema and incidence of allergic rhinitis and wheeze in 5-year-old children
(Hazard ratios (HR), odds ratios and 95% confidence intervals)
Atopic eczema Allergic rhinitis Wheeze
Unadjusted Adjusted model I† Unadjusted Adjusted model I† Unadjusted Adjusted model I†
Fatty acids OR 95 % CI OR 95 % CI HR 95 % CI HR 95 % CI HR 95 % CI HR 95 % CI
Total fatty acids
First quarter (,196·85 g/d) 0·89 0·72, 1·09 0·84 0·68, 1·04 0·93 0·71, 1·20 0·92 0·70, 1·20 1·02 0·80, 1·28 1·03 0·81, 1·33
Second and third quarters (196·85–280·83 g/d) 1 1 1 1 1 1
Fourth quarter (280·84–299·25 g/d) 1·03 0·85, 1·26 1·04 0·84, 1·28 0·96 0·75, 1·24 0·98 0·75, 1·27 0·99 0·79, 1·25 0·95 0·74, 1·21
SFA
First quarter (,82·24 g/d) 1·01 0·83, 1·24 0·99 0·80, 1·23 1·07 0·83, 1·38 1·06 0·82, 1·39 1·00 0·80, 1·26 0·99 0·79, 1·27
Second and third quarters (82·24–118·56 g/d) 1 1 1 1 1 1
Fourth quarter (118·57–145·84 g/d) 1·04 0·85, 1·27 1·03 0·84, 1·27 1·10 0·85, 1·41 1·06 0·82, 1·37 0·89 0·70, 1·12 0·80 0·63, 1·03
Trans-fatty acids
First quarter (,3·10 g/d) 0·95 0·78, 1·16 0·84 0·68, 1·04 1·00 0·77, 1·30 0·95 0·72, 1·25 0·96 0·76, 1·21 1·03 0·80, 1·31
Second and third quarters (3·10–4·18 g/d) 1 1 1 1 1 1
Fourth quarter (4·19–7·73 g/d) 0·78* 0·62, 0·99 1·08 0·88, 1·33 1·17 0·91, 1·49 1·14 0·89, 1·46 0·85 0·67, 1·07 0·83 0·64, 1·06
MUFA
First quarter (,78·05 g/d) 0·94 0·77, 1·15 0·90 0·73, 1·11 0·89 0·68, 1·15 0·89 0·68, 1·17 0·94 0·74, 1·18 0·98 0·77, 1·25
Second and third quarters (78·05–93·52 g/d) 1 1 1 1 1 1
Fourth quarter (93·53–104·16 g/d) 0·98 0·81, 1·20 0·98 0·80, 1·21 0·95 0·74, 1·22 0·96 0·74, 1·24 1·02 0·81, 1·29 1·08 0·85, 1·38
PUFA
First quarter (,22·90 g/d) 1·02 0·83, 1·25 0·94 0·76, 1·17 0·90 0·70, 1·16 0·82 0·63, 1·07 0·93 0·74, 1·17 0·94 0·73, 1·21
Second and third quarters (22·90–32·46 g/d) 1 1 1 1 1 1
Fourth quarter (32·47–59·37 g/d) 1·00 0·82, 1·22 1·03 0·83, 1·27 0·75* 0·57, 0·97 0·73* 0·55, 0·96 1·01 0·80, 1·28 1·08 0·84, 1·40
Ratio of n-6 to n-3 PUFA
First quarter 0·97 0·80, 1·19 0·99 0·80, 1·22 1·08 0·84, 1·40 1·09 0·84, 1·43 0·90 0·71, 1·13 0·85 0·66, 1·10
Second and third quarters 1 1 1 1 1 1
Fourth quarter 0·94 0·77, 1·15 1·01 0·82, 1·24 1·28* 1·00, 1·64 1·35* 1·05, 1·73 1·14 0·90, 1·43 1·09 0·85, 1·40
n-6 PUFA
First quarter (,19·32 g/d) 1·03 0·85, 1·26 0·97 0·78, 1·20 0·92 0·71, 1·18 0·85 0·66, 1·11 1·01 0·80, 1·27 1·01 0·79, 1·30
Second and third quarters (19·32–24·50 g/d) 1 1 1 1 1 1
Fourth quarter (24·51–49·23 g/d) 1·10 0·90, 1·35 1·15 0·93, 1·43 0·86 0·66, 1·12 0·84 0·64, 1·11 1·15 0·92-1·45 1·21 0·94-1·55
Linoleic fatty acid
First quarter (,18·64 g/d) 1·05 0·86, 1·28 0·98 0·79, 1·21 0·93 0·72, 1·19 0·86 0·66, 1·12 1·00 0·80, 1·26 1·01 0·79, 1·30
Second and third quarters (18·64–23·87 g/d) 1 1 1 1 1 1
Fourth quarter (23·87–47·75 g/d) 1·14 0·93, 1·39 1·17 0·95, 1·45 0·85 0·65, 1·10 0·83 0·63, 1·09 1·14 0·91, 1·44 1·20 0·94, 1·53
Linoleic fatty acid, conjugated
First quarter (,0·38 g/d) 0·96 0·79, 1·18 0·93 0·75, 1·15 0·98 0·76, 1·27 0·98 0·75, 1·27 1·09 0·87, 1·38 1·19 0·93, 1·52
Second and third quarters (0·38–0·54 g/d) 1 1 1 1 1 1
Fourth quarter (0·54–0·75 g/d) 1·01 0·83, 1·23 1·01 0·82, 1·24 0·99 0·77, 1·27 0·96 0·74, 1·25 0·93 0·73, 1·18 0·88 0·69, 1·14
g-Linolenic fatty acid
First quarter (,0·11 g/d) 0·90 0·73, 1·10 0·91 0·73, 1·12 1·01 0·78, 1·30 1·07 0·82, 1·39 1·14 0·91, 1·44 1·20 0·94, 1·53
Second and third quarters (0·11–0·16 g/d) 1 1 1 1 1 1
Fourth quarter (0·16–0·98 g/d) 1·05 0·86, 1·28 1·05 0·86, 1·30 1·04 0·81, 1·33 1·08 0·83, 1·39 0·94 0·74, 1·19 0·96 0·74, 1·24
Arachidonic fatty acid
First quarter (,0·14 g/d) 1·03 0·85, 1·27 1·02 0·82, 1·26 0·82 0·63, 1·07 0·86 0·66, 1·14 0·88 0·69, 1·13 0·95 0·73, 1·23
Second and third quarters (0·14–0·20 g/d) 1 1 1 1 1 1
Fourth quarter (0·20–0·44 g/d) 1·04 0·86, 1·27 1·02 0·83, 1·25 1·04 0·81, 1·32 1·04 0·81, 1·34 0·85 0·68, 1·06 0·93 0·73, 1·17
n-3 PUFA
First quarter (,5·55 g/d) 1·08 0·88, 1·32 1·03 0·84, 1·27 0·91 0·71, 1·17 0·89 0·69, 1·15 0·89 0·71, 1·12 0·98 0·77, 1·25
Second and third quarters (5·55–7·34 g/d) 1 1 1 1 1 1
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Table 4. Continued
Atopic eczema Allergic rhinitis Wheeze
Unadjusted Adjusted model I† Unadjusted Adjusted model I† Unadjusted Adjusted model I†
Fatty acids OR 95 % CI OR 95 % CI HR 95 % CI HR 95 % CI HR 95 % CI HR 95 % CI
Fourth quarter (7·35–11·28 g/d) 0·94 0·77, 1·15 0·93 0·75, 1·14 0·78 0·60, 1·02 0·82 0·63, 1·08 0·95 0·75, 1·21 1·11 0·85, 1·43
n-3 PUFA from fish‡
First quarter (,0·38 g/d) 1·16 0·95, 1·42 1·16 0·93, 1·43 0·99 0·77, 1·28 0·99 0·76, 1·28 1·15 0·92, 1·45 1·08 0·85, 1·38
Second and third quarters (0·38–0·98 g/d) 1 1 1 1 1 1
Fourth quarter (0·99–5·50 g/d) 0·96 0·79, 1·18 0·97 0·79, 1·20 0·91 0·71, 1·17 0·94 0·72, 1·22 0·95 0·75, 1·20 0·95 0·74, 1·22
n-3 PUFA from plants
First quarter (,4·79 g/d) 1·02 0·83, 1·24 0·97 0·78, 1·19 1·02 0·80, 1·30 0·97 0·75, 1·25 0·86 0·69, 1·08 0·94 0·74, 1·19
Second and third quarters (4·79–6·27 g/d) 1 1 1 1 1 1
Fourth quarter (6·28–8·97 g/d) 0·93 0·76, 1·14 0·92 0·74, 1·14 0·80 0·61, 1·04 0·79 0·60, 1·05 0·88 0·69, 1·11 0·94 0·73, 1·21
a-Linolenic fatty acid
First quarter (,4·45 g/d) 1·08 0·89, 1·32 1·05 0·86, 1·30 1·06 0·83, 1·35 1·01 0·79, 1·29 0·79 0·63, 0·99 0·87 0·69, 1·11
Second and third quarters (4·45–6·40 g/d) 1 1 1 1 1 1
Fourth quarter (6·40–8·90 g/d) 1·01 0·83, 1·23 0·99 0·80, 1·23 0·74* 0·56, 0·97 0·74* 0·56, 0·99 0·87 0·69, 1·10 0·95 0·74, 1·22
EPA
First quarter (,0·07 g/d) 1·09 0·89, 1·34 1·07 0·86, 1·33 1·02 0·79, 1·32 0·99 0·76, 1·29 1·05 0·83, 1·32 1·01 0·79, 1·29
Second and third quarters (0·07–0·23 g/d) 1 1 1 1 1 1
Fourth quarter (0·23–1·25 g/d) 0·96 0·78, 1·17 0·94 0·76, 1·16 1·00 0·78, 1·29 0·99 0·76, 1·28 0·97 0·77, 1·23 0·98 0·76, 1·26
DHA
First quarter (,0·19 g/d) 1·21 0·99, 1·48 1·18 0·95, 1·46 1·00 0·78, 1·29 0·94 0·72, 1·22 1·10 0·87, 1·38 1·06 0·83, 1·36
Second and third quarters (0·19–0·60 g/d) 1 1 1 1 1 1
Fourth quarter (0·60–3·5 g/d) 0·98 0·81, 1·20 0·98 0·79, 1·20 0·94 0·73, 1·21 0·93 0·72, 1·21 0·94 0·74, 1·19 0·93 0·73, 1·20
*P,0·05.
† Adjusted for sex of child, hospital of birth, duration of gestation, maternal age at delivery, maternal basic education, maternal smoking during pregnancy, mode of delivery, number of siblings at the time of the child’s birth,
parental asthma, parental allergic rhinitis, pets at home by 1 year of age.
‡ n-3 PUFA from fish is a summary variable including all n-3 fatty acids from fish and fish products.
B
.
I.
N
w
aru
et
a
l.
7
2
8
British Journal of Nutrition
Table 5. Association between maternal fatty acid intake during pregnancy and prevalence of atopic eczema and incidence of allergic
rhinitis and wheeze in 5-year-old children
(Hazard ratios (HR), odds ratios and 95% confidence intervals)
Atopic eczema Allergic rhinitis Wheeze
Adjusted model II† Adjusted model II† Adjusted model II†
OR 95 % CI HR 95 % CI OR 95 % CI
Total fatty acids
First quarter (,196·85 g/d) 0·84 0·67, 1·05 0·94 0·71, 1·24 1·09 0·84, 1·41
Second and third quarters (196·85–280·83 g/d) 1 1 1
Fourth quarter (280·84–299·25 g/d) 1·03 0·83, 1·28 0·96 0·73, 1·25 0·93 0·72, 1·19
SFA
First quarter (,82·24 g/d) 1·00 0·80, 1·24 1·08 0·83, 1·41 1·0 0·78, 1·29
Second and third quarters (82·24–118·56 g/d) 1 1 1
Fourth quarter (118·57–145·84 g/d) 1·0 0·81, 1·24 1·00 0·76, 1·31 0·77 0·59, 1·00
Trans-fatty acids
First quarter (,3·10 g/d) 0·84 0·68, 1·05 0·98 0·74, 1·29 1·08 0·84, 1·40
Second and third quarters (3·10–4·18 g/d) 1 1 1
Fourth quarter (4·19–7·73 g/d) 1·07 0·87, 1·32 1·09 0·85, 1·41 0·80 0·62, 1·03
MUFA
First quarter (,78·05 g/d) 0·90 0·72, 1·12 0·90 0·68, 1·19 1·02 0·79, 1·32
Second and third quarters (78·05–93·52 g/d) 1 1 1
Fourth quarter (93·53–104·16 g/d) 0·98 0·79, 1·23 0·97 0·73, 1·27 1·08 0·83, 1·40
PUFA
First quarter (,22·90 g/d) 0·92 0·73, 1·16 0·81 0·61, 1·07 0·92 0·70, 1·21
Second and third quarters (22·90–32·46 g/d) 1 1 1
Fourth quarter (32·47–59·37 g/d) 1·03 0·81, 1·31 0·71* 0·52, 0·96 1·09 0·82, 1·44
Ratio of n-6 to n-3 PUFA
First quarter 1·00 0·80, 1·23 1·10 0·84, 1·44 0·86 0·66, 1·11
Second and third quarters 1 1 1
Fourth quarter 1·01 0·82, 1·25 1·37* 1·07, 1·77 1·08 0·84, 1·38
n-6 PUFA
First quarter (,19·32 g/d) 0·92 0·74, 1·16 0·82 0·62, 1·10 1·0 0·76, 1·32
Second and third quarters (19·32–24·50 g/d) 1 1 1
Fourth quarter (24·51–49·23 g/d) 1·19 0·94, 1·50 0·83 0·62, 1·12 1·17 0·90, 1·54
Linoleic fatty acid
First quarter (,18·64 g/d) 0·94 0·75, 1·18 0·85 0·64, 1·12 1·0 0·76, 1·32
Second and third quarters (18·64–23·87 g/d) 1 1 1
Fourth quarter (23·87–47·75 g/d) 1·21 0·96, 1·52 0·81 0·60, 1·09 1·15 0·88, 1·51
Linoleic fatty acid, conjugated
First quarter (,0·38 g/d) 0·94 0·76, 1·16 1·00 0·77, 1·30 1·24 0·97, 1·59
Second and third quarters (0·38–0·54 g/d) 1 1 1
Fourth quarter (0·54–0·75 g/d) 0·99 0·79, 1·22 0·91 0·70, 1·19 0·84 0·65, 1·10
g-Linolenic fatty acid
First quarter (,0·11 g/d) 0·91 0·73, 1·12 1·06 0·82, 1·38 1·22 0·95, 1·56
Second and third quarters (0·11–0·16 g/d) 1 1 1
Fourth quarter (0·16–0·98 g/d) 1·04 0·84, 1·28 1·04 0·80, 1·35 0·97 0·74, 1·27
Arachidonic fatty acid
First quarter (,0·14 g/d) 0·98 0·78, 1·23 0·80 0·60, 1·07 0·98 0·74, 1·31
Second and third quarters (0·14–0·20 g/d) 1 1 1
Fourth quarter (0·20–0·44 g/d) 1·06 0·85, 1·33 1·13 0·86, 1·48 0·87 0·68, 1·11
n-3 PUFA
First quarter (,5·55 g/d) 1·03 0·82, 1·28 0·84 0·64, 1·10 0·97 0·75, 1·25
Second and third quarters (5·55–7·34 g/d) 1 1 1
Fourth quarter (7·35–11·28 g/d) 0·91 0·73, 1·14 0·85 0·64, 1·14 1·14 0·87, 1·49
n-3 PUFA from fish‡
First quarter (,0·38 g/d) 1·13 0·90, 1·42 0·91 0·69, 1·20 1·08 0·84, 1·39
Second and third quarters (0·38–0·98 g/d) 1 1 1
Fourth quarter (0·99–5·50 g/d) 1·00 0·80, 1·26 1·05 0·80, 1·40 0·97 0·73, 1·28
n-3 PUFA from plants
First quarter (,4·79 g/d) 0·96 0·77, 1·19 0·95 0·73, 1·24 0·95 0·74, 1·22
Second and third quarters (4·79–6·27 g/d) 1 1 1
Fourth quarter (6·28–8·97 g/d) 0·90 0·72, 1·12 0·78 0·58, 1·04 0·93 0·72, 1·21
a-Linolenic fatty acid
First quarter (,4·45 g/d) 1·05 0·85, 1·30 1·01 0·78, 1·30 0·87 0·67, 1·12
Second and third quarters (4·45–6·40 g/d) 1 1 1
Fourth quarter (6·40–8·90 g/d) 0·98 0·78, 1·22 0·73* 0·54, 0·98 0·95 0·73, 1·23
EPA
First quarter (,0·07 g/d) 1·04 0·83, 1·31 0·90 0·68, 1·19 1·0 0·77, 1·29
Second and third quarters (0·07–0·23 g/d) 1 1 1
Fourth quarter (0·23–1·25 g/d) 0·97 0·77, 1·22 1·12 0·84, 1·48 1·03 0·78, 1·36
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actual allergic manifestations. The role of supplementation
with n-3 and n-6 PUFA for primary prevention of allergic
outcomes has provided inconclusive evidence(33–37).
Recently, it has been suggested that the ratio of n-6:n-3 FA,
rather than the intake of their absolute amount, may represent
a more important indicator of optimum health(38,39). Although
previous studies have been inconsistent(4,39), the results
from the present study, however, show that a higher ratio of
n-6:n-3 FA was associated with an increased risk of rhinitis
in the offspring by the age of 5 years. While this finding
is in line with the results of an Australian study reporting
an enhanced risk of asthma in children aged 8 years with a
higher ratio of n-6:n-3 FA during pregnancy(39), it is at odds
with that of a recent Japanese study reporting no associ-
ation(32). In a previous US cohort, cord blood ratios of
AA:EPA and linoleic acid:a-linolenic acid were positively
associated with eczema and wheeze, respectively, while the
ratio of a-linolenic acid:n-3 PUFA was inversely associated
with wheeze in 30- to 42-month-old toddlers(40). In another
US study, higher n-3 EPA, n-6 AA and a reduced ratio of
AA:EPA were associated with reduced allergen-stimulated
interferon-g levels in neonates(41).
We found an increased risk of rhinitis with high maternal
consumption of butter. It has been hypothesised that margar-
ines may increase the risk of allergies, whereas butter may
decrease the risk(2). The present results of no association
between consumption of margarines and the risks of allergies
did not support this proposition. In addition, our data on
butter are in contrast to the hypothesised role of butter in
the development of allergies, and also contradictory to the
present observation on the effect of the ratio of n-6:n-3 FA
on the risk of rhinitis, considering that n-6 FA are particularly
derived from margarines. We lack the explanation for these
disparities, but as earlier noted, it may highlight the complex
mechanisms relating FA to the development of allergies,
especially during early life. In a German cohort, maternal
consumption of margarine but not butter during pregnancy
was associated with an increased risk of allergies in the
offspring(42), whereas an Italian retrospective cohort study
found no association between either maternal consumption
of butter or margarine and atopy in the offspring(6). Oily
fish is a major source of n-3 PUFA, and its consumption
during pregnancy has been related to a reduced risk
of asthma(7), eczema(9,10), house dust mite, wheeze(9) and
allergic sensitisation(6,8) in the offspring. In contrast, in an
8-year longitudinal follow-up study from The Netherlands,
maternal fish consumption during pregnancy was not associ-
ated with asthma or any asthma symptom in the offspring(11).
We did not have a measure of oily fish in the present
study; therefore, we were unable to assess its association
with the endpoints.
Conclusion
The present data indicate that maternal consumption of butter,
the ratio of n-6:n-3 PUFA, and intake of PUFA and a-linolenic
during pregnancy may be potential determinants of the deve-
lopment of allergic rhinitis in the offspring. In the light of
discordant reports, more evidence is needed to confirm and
further define the putative role of dietary butter and FA in
the current increasing prevalence of allergic diseases.
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Table 5. Continued
Atopic eczema Allergic rhinitis Wheeze
Adjusted model II† Adjusted model II† Adjusted model II†
OR 95 % CI HR 95 % CI OR 95 % CI
DHA
First quarter (,0·19 g/d) 1·15 0·92, 1·45 0·85 0·64, 1·12 1·04 0·80, 1·34
Second and third quarters (0·19–0·60 g/d) 1 1 1
Fourth quarter (0·60–3·5 g/d) 1·00 0·80, 1·26 1·05 0·79, 1·39 0·95 0·72, 1·26
*P,0·05.
† In addition to the covariates in model I, adjusted for energy-adjusted maternal intake of vitamin C, Zn, Se, vitamin D and vitamin E.
‡ n-3 PUFA from fish is a summary variable including all n-3 fatty acids from fish and fish products.
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for 5-year-olds. M. L. participated in the data analysis,
interpretation, preparation and review of the manuscript and
revising it critically for important intellectual content. S. A.
and C. K.-K. were responsible for the data acquisition and
preparation, interpretation of the results and critically review-
ing the manuscript. R. V., J. I., O. S. and M. K. were respon-
sible for data collection in the clinics and for paediatric
expertise in this study, and review of the manuscript and revis-
ing it critically for important intellectual content.
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